These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

572 related items for PubMed ID: 15378019

  • 1. AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity.
    Liu Y, Lu C, Shen Q, Munoz-Medellin D, Kim H, Brown PH.
    Oncogene; 2004 Oct 28; 23(50):8238-46. PubMed ID: 15378019
    [Abstract] [Full Text] [Related]

  • 2. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
    Shen Q, Uray IP, Li Y, Krisko TI, Strecker TE, Kim HT, Brown PH.
    Oncogene; 2008 Jan 10; 27(3):366-77. PubMed ID: 17637753
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth.
    Liu Y, Ludes-Meyers J, Zhang Y, Munoz-Medellin D, Kim HT, Lu C, Ge G, Schiff R, Hilsenbeck SG, Osborne CK, Brown PH.
    Oncogene; 2002 Oct 31; 21(50):7680-9. PubMed ID: 12400010
    [Abstract] [Full Text] [Related]

  • 4. Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells.
    Zhu WY, Jones CS, Kiss A, Matsukuma K, Amin S, De Luca LM.
    Exp Cell Res; 1997 Aug 01; 234(2):293-9. PubMed ID: 9260897
    [Abstract] [Full Text] [Related]

  • 5. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.
    Wang H, Shao N, Ding QM, Cui J, Reddy ES, Rao VN.
    Oncogene; 1997 Jul 10; 15(2):143-57. PubMed ID: 9244350
    [Abstract] [Full Text] [Related]

  • 6. cFos is critical for MCF-7 breast cancer cell growth.
    Lu C, Shen Q, DuPré E, Kim H, Hilsenbeck S, Brown PH.
    Oncogene; 2005 Sep 29; 24(43):6516-24. PubMed ID: 16027729
    [Abstract] [Full Text] [Related]

  • 7. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
    Yin F, Giuliano AE, Law RE, Van Herle AJ.
    Anticancer Res; 2001 Sep 29; 21(1A):413-20. PubMed ID: 11299771
    [Abstract] [Full Text] [Related]

  • 8. c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases.
    Alexandrow MG, Moses HL.
    J Cell Biochem; 1998 Sep 15; 70(4):528-42. PubMed ID: 9712150
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor.
    Khwaja F, Djakiew D.
    Mol Carcinog; 2003 Mar 15; 36(3):153-60. PubMed ID: 12619038
    [Abstract] [Full Text] [Related]

  • 10. Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: increased binding of cyclin A negatively regulates E2F transactivation activity.
    Turley JM, Ruscetti FW, Kim SJ, Fu T, Gou FV, Birchenall-Roberts MC.
    Cancer Res; 1997 Jul 01; 57(13):2668-75. PubMed ID: 9205075
    [Abstract] [Full Text] [Related]

  • 11. Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis.
    Sprenger CC, Vail ME, Evans K, Simurdak J, Plymate SR.
    Oncogene; 2002 Jan 03; 21(1):140-7. PubMed ID: 11791184
    [Abstract] [Full Text] [Related]

  • 12. Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells.
    Tomari K, Kumagai T, Shimizu T, Takeda K.
    Int J Mol Med; 2005 Feb 03; 15(2):253-8. PubMed ID: 15647840
    [Abstract] [Full Text] [Related]

  • 13. [G1 block of the cell cycle during differentiation of F9 cells correlates with accumulation of inhibitors of the activity of cyclin-kinase complexes of proteins p21/Waf1 and p27/Kip].
    Malashicheva AB, Kisliakova TV, Pospelov VA.
    Tsitologiia; 2002 Feb 03; 44(7):649-55. PubMed ID: 12455373
    [Abstract] [Full Text] [Related]

  • 14. Blockade of AP-1 activity by dominant-negative TAM67 can abrogate the oncogenic phenotype in latent membrane protein 1-positive human nasopharyngeal carcinoma.
    Jin X, Song X, Li L, Wang Z, Tao Y, Deng L, Tang M, Yi W, Cao Y.
    Mol Carcinog; 2007 Nov 03; 46(11):901-11. PubMed ID: 17477349
    [Abstract] [Full Text] [Related]

  • 15. Ectopic expression of cyclin E in estrogen responsive cells abrogates antiestrogen mediated growth arrest.
    Dhillon NK, Mudryj M.
    Oncogene; 2002 Jul 11; 21(30):4626-34. PubMed ID: 12096339
    [Abstract] [Full Text] [Related]

  • 16. Deregulated expression of cell-cycle proteins during premalignant progression in SENCAR mouse skin.
    Rodriguez-Puebla ML, LaCava M, Gimenez-Conti IB, Johnson DG, Conti CJ.
    Oncogene; 1998 Oct 29; 17(17):2251-8. PubMed ID: 9811455
    [Abstract] [Full Text] [Related]

  • 17. Anticarcinogenic effect of a flavonoid antioxidant, silymarin, in human breast cancer cells MDA-MB 468: induction of G1 arrest through an increase in Cip1/p21 concomitant with a decrease in kinase activity of cyclin-dependent kinases and associated cyclins.
    Zi X, Feyes DK, Agarwal R.
    Clin Cancer Res; 1998 Apr 29; 4(4):1055-64. PubMed ID: 9563902
    [Abstract] [Full Text] [Related]

  • 18. Activation of c-Myc uncouples DNA replication from activation of G1-cyclin-dependent kinases.
    Pusch O, Bernaschek G, Eilers M, Hengstschläger M.
    Oncogene; 1997 Aug 07; 15(6):649-56. PubMed ID: 9264405
    [Abstract] [Full Text] [Related]

  • 19. Rb dephosphorylation and suppression of E2F activity in human breast tumor cells exposed to a pharmacological concentration of estradiol.
    Gewirtz DA, Di YM, Randolph JK, Jain PT, Valerie K, Bullock S, Nath N, Chellappan SP.
    Arch Biochem Biophys; 2001 Apr 15; 388(2):243-52. PubMed ID: 11368161
    [Abstract] [Full Text] [Related]

  • 20. AP-1 blockade inhibits the growth of normal and malignant breast cells.
    Ludes-Meyers JH, Liu Y, Muñoz-Medellin D, Hilsenbeck SG, Brown PH.
    Oncogene; 2001 May 17; 20(22):2771-80. PubMed ID: 11420689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.